1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsInteragency Oncology Task Force Fellowship is sponsored by National Cancer Institute (NCI). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Interagency Oncology Task Force Fellowship - NCI Interagency Oncology Task Force Fellowship The Interagency Oncology Task Force Fellowship (IOTF) program trains scientists in research and research-related regulatory review, policies, and regulations to develop a skill set that bridges the two disparate processes.
Fellows learn to build awareness of regulatory requirements into the early stages of the medical product development process and will develop strategies to improve planning throughout research and regulatory review. The fellowship is offered as a partnership of the National Cancer Institute (NCI), National Institutes of Health (NIH), and U.S. Food and Drug Administration (FDA), and the U.S. Department Health and Human Services (HHS).
*Selection of fellows will be dependent upon the availability of funds. Note eligibility requirement for all IOTF tracks: U.S. citizenship or permanent residents, who have resided in the US for a total of three of the past five years. Applications typically open in May, with an early October start date.
For more details about the current application cycle, please visit the Train at NCI application system. Track 1: Oncology Product Research and Review for M. D.
Oncology Fellows This fellowship will train physicians in aspects of clinical trials methodology and analysis, epidemiology, clinical aspects of medical product development, and regulation to facilitate the movement of drugs, biologics, and devices from the basic bench science to commercialization. Track 2: Oncology Product Research and Review for B. C.
Oncologists This fellowship will train physicians in aspects of drug, biologic, or device development and related issues and standards to facilitate movement from basic bench science to commercialization.
Track 3: Oncology Product Research and Review for Postdoctoral Research Fellows This fellowship will train individuals with postdoctoral research experience in aspects of research and review of the medical product development process to facilitate the movement of drugs, biologics, and devices from the bench to the bedside.
Track 4: Cancer Prevention Product Research and Review This fellowship will train individuals in aspects of the cancer prevention drug, biologic, or device development processes, including their application to study populations, to facilitate the movement of novel approaches from the bench to the community. Current and Alumni Fellows Meet the current and alumni IOTF fellows.
Learn how IOTF relates to fellows' professional background, research interests, and career goals. Chanelle Case Borden, Ph. D.
National Cancer Institute 9609 Medical Center Drive E-mail: IOTFfellowship@nih. gov Leslie D. Wheelock, MS, RN U.S. Food and Drug Administration (FDA)Office of Chief Scientist Office of Scientific Professional Development E-mail: leslie.
wheelock@fda. hhs. gov Expiration Date: 07/31/2025 Public reporting burden for this collection of information is estimated to average 60 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing he collection of information.
An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0761).
Do not return the completed form to this address.
According to the current listing, eligibility includes: Open to U. S. citizens or permanent residents who have resided in the U. S. for at least three of the past five years. Confirm the full requirements in the official notice before applying.
Interagency Oncology Task Force Fellowship is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article